Strong Trigger
now
Enters final PMA review stage with the US FDA for 'Eversense', the first-ever 365-day implantable continuous glucose monitoring system.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |